首页> 外文期刊>International Journal of Molecular Sciences >Mast Cells Density Positive to Tryptase Correlate with Microvascular Density in both Primary Gastric Cancer Tissue and Loco-Regional Lymph Node Metastases from Patients That Have Undergone Radical Surgery
【24h】

Mast Cells Density Positive to Tryptase Correlate with Microvascular Density in both Primary Gastric Cancer Tissue and Loco-Regional Lymph Node Metastases from Patients That Have Undergone Radical Surgery

机译:胰蛋白酶阳性的肥大细胞密度与原发性胃癌患者原发性胃癌组织和局部淋巴结转移中的微血管密度相关

获取原文
           

摘要

Mast Cells (MCs) play a role in immune responses and more recently MCs have been involved in tumoral angiogenesis. In particular MCs can release tryptase, a potent in vivo and in vitro pro-angiogenic factor via proteinase-activated receptor-2 (PAR-2) activation and mitogen-activated protein kinase (MAPK) phosphorylation. MCs can release tryptase following c-Kit receptor activation. Nevertheless, no data are available concerning the relationship among MCs Density Positive to Tryptase (MCDPT) and Microvascular Density (MVD) in both primary gastric cancer tissue and loco-regional lymph node metastases. A series of 75 GC patients with stage T 2–3 N 2–3 M 0 (by AJCC for Gastric Cancer Seventh Edition) undergone to radical surgery were selected for the study. MCDPT and MVD were evaluated by immunohistochemistry and by image analysis system and results were correlated each to other in primary tumor tissue and in metastatic lymph nodes harvested. Furthermore, tissue parameters were correlated with important clinico-pathological features. A significant correlation between MCDPT and MVD was found in primary gastric cancer tissue and lymph node metastases. Pearson t -test analysis ( r ranged from 0.74 to 0.79; p -value ranged from 0.001 to 0.003). These preliminary data suggest that MCDPT play a role in angiogenesis in both primary tumor and in lymph node metastases from GC. We suggest that MCs and tryptase could be further evaluated as novel targets for anti-angiogenic therapies.
机译:肥大细胞(MC)在免疫应答中起作用,最近,MC已参与肿瘤血管生成。特别是,MCs可以通过蛋白酶激活的受体2(PAR-2)激活和有丝分裂原激活的蛋白激酶(MAPK)磷酸化释放类胰蛋白酶,这是一种有效的体内和体外促血管生成因子。 MC可以在c-Kit受体激活后释放类胰蛋白酶。然而,在原发性胃癌组织和局部淋巴结转移中,尚无关于类胰蛋白酶阳性的MC密度(MCDPT)和微血管密度(MVD)之间关系的数据。选择了75例接受过根治性手术的T 2–3 N 2–3 M 0分期的胃癌患者(由AJCC出版,用于第七版)。 MCDPT和MVD通过免疫组织化学和图像分析系统进行了评估,结果在原发肿瘤组织和转移的淋巴结中相互关联。此外,组织参数与重要的临床病理特征相关。在原发性胃癌组织和淋巴结转移中发现了MCDPT和MVD之间的显着相关性。皮尔逊t检验分析(r介于0.74至0.79; p值介于0.001至0.003之间)。这些初步数据表明,MCDPT在原发肿瘤和GC淋巴结转移中均在血管生成中起作用。我们建议MC和类胰蛋白酶可以进一步评估为抗血管生成疗法的新目标。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号